Similarly, in a rat model of diabetes, the intracerebroventricular (i.c.v) injection of FGF1 delayed the onset of β-cell dysfunction without an effect on glucose-induced insulin secretion or insulin sensitivity, suggesting that FGF1 can act in the brain to stimulate insulin-independent glucose clearance [21]. Here, INS is linked to diabetes mellitus.